2 Biotech Stocks to Buy Before They Soar 84% and 240%, According to Certain Wall Street Analysts

If you're looking to add growth to your portfolio, biotech stocks can be a great choice. As an investor in these companies, you can benefit as they report positive clinical trial news, score a regulatory approval, or start generating product revenue. Wall Street considers two candidates extremely compelling right now, with forecasts for potential gains of more than 80% and 200% in the coming 12 months.